Clinical Safety

Does Your Diet's Melatonin Fight Obesity and Depression?
Research & Development Does Your Diet's Melatonin Fight Obesity and Depression?

The intricate connection between what we eat and how we feel extends far beyond calories and vitamins, reaching into the complex world of hormones naturally present in our daily meals. While widely recognized as the body's sleep regulator, melatonin is emerging from the shadows of the circadian

First Topical CRISPR Therapy Treats Genetic Skin Disease
Research & Development First Topical CRISPR Therapy Treats Genetic Skin Disease

For individuals living with debilitating genetic skin disorders, effective treatments have remained elusive, often limited to managing symptoms rather than addressing the root cause encoded in their DNA. A groundbreaking development from researchers at the University of British Columbia and the

New Trials Are Reshaping Bladder Cancer Care
Research & Development New Trials Are Reshaping Bladder Cancer Care

The treatment paradigm for bladder cancer is undergoing a seismic shift, as a new wave of clinical research moves beyond traditional protocols to pioneer a more integrated, intelligent, and immune-focused approach to care. This evolution is not merely about refining existing methods but about

Study Links Lifetime Alcohol Use to Colorectal Cancer Risk
Research & Development Study Links Lifetime Alcohol Use to Colorectal Cancer Risk

While the dangers of heavy drinking are widely acknowledged, a landmark study has now illuminated the profound and cumulative risk that a lifetime of alcohol consumption poses for the development of colorectal cancer. Moving beyond simple snapshots of current habits, this comprehensive analysis

FDA Partially Lifts Hold on Intellia CRISPR Trial
Research & Development FDA Partially Lifts Hold on Intellia CRISPR Trial

Today we’re joined by Ivan Kairatov, a biopharma expert with deep experience in drug development and the intricate dance between innovation, regulation, and market perception. We'll be dissecting the recent developments with Intellia Therapeutics, a pioneer in CRISPR gene editing. The company has

What Is the Double-Edged Sword of Cancer Fibroblasts?
Research & Development What Is the Double-Edged Sword of Cancer Fibroblasts?

Within the intricate ecosystem of a tumor, cancer cells are far from acting alone; they are surrounded by a complex network of supporting cells that form the tumor microenvironment. Among these collaborators, cancer-associated fibroblasts (CAFs) have emerged as particularly influential players.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later